drug target discovery

History:

Formerly Arcaris; acquired by Deltagen in July 2001. Deltagen Proteomics ceased operations in early 2003 as part of a cost savings measure by the parent company.

Employment

Email:

Fax:

Mail:

General Info:

Ticker:

Employees:

Regions:
Other US

Research Focus:
Assay Proteomics Disease Therapeutics-Research

 

Profiles:

 

News:

Keywords: 

Strategic Partnerships: